journal article·2018-11-12

MRI tracking of polyethylene glycol-coated superparamagnetic iron oxide-labelled placenta-derived mesenchymal stem cells toward glioblastoma stem-like cells in a mouse model

Fei-Ting Hsu, Zung-Hang Wei, Yogi Chang-Yo Hsuan, Willie Lin, Yu-Chin Su, Chia-Hui Liao, Chia-Ling Hsieh

Publisher page

Abstract

Mesenchymal stem cells (MSCs) that display homing and infiltration properties towards tumor cells are a promising cellular targeting vector for brain tumor therapy but are limited to local-regional delivery in current preclinical models. Here, we investigated whether placenta-derived MSCs (P-MSCs) are a superior cellular vector for systemic targeting of glioblastoma stem-like cells (GSCs), with an imaging modality to real-time monitor the trafficking P-MSCs to glioblastoma sites. Results demonstrated that P-MSCs had greater migratory activity towards GSCs and across blood-brain barrier compared with bone marrow-derived MSCs, and this activity was enhanced by hypoxia precondition. Chemokine ligand 5 was identified as a chemoattractant responsible for the glioblastoma tropism of P-MSCs. Polyethylene glycol-coated superparamagnetic iron oxide (PEG-SPIO) was synthesized for cellular labelling and imaging P-MSCs, displaying high cellular uptake and no cytotoxic effect on P-MSCs cell proliferation or stemness property. The homing effects of intravenously administered PEG-SPIO-labelled P-MSCs towards intracerebral GSCs were able to be detected in mice models through T2-weighted magnetic resonance imaging (MRI). This study suggests the possibility of innovative systemic P-MSC-based cell therapy for aggressive GSCs, developing a state-of-the-art theranostic technique for real-time tracking of therapeutic P-MSCs tumor infiltration through cellular MRI.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Mesenchymal stem cell research · Cancer Cells and Metastasis · Glioma Diagnosis and Treatment

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Radiology, School of Medicine, College of Medicine, Taipei Medical University

Department of Biological Science and Technology, China Medical University

Department of Medical Imaging, Taipei Medical University Hospital

Research Center of Translational Imaging, College of Medicine, Taipei Medical University

Department of Power Mechanical Engineering, National Tsing Hua University

Meridigen Biotech Co., Ltd

The PhD Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University

Clinical Research Center, Taipei Medical University Hospital, Taipei Medical University

TMU Research Center of Cancer Translational Medicine, Taipei Medical University

Funding

Taipei Medical University Hospital · Meridigen Biotech Co., Ltd. · Ministry of Science and Technology of Taiwan · Ministry of Education

References (58)

Show source-provided references
1. 10.1056/NEJMoa04333010.1056/NEJMoa043330 ↗
2. 10.1101/gad.261982.11510.1101/gad.261982.115 ↗
3. 10.1038/3510216710.1038/35102167 ↗
4. 10.1023/A:101310442315410.1023/A:1013104423154 ↗
5. 10.3389/fonc.2014.0012610.3389/fonc.2014.00126 ↗
6. 10.1517/14728222.2012.71477410.1517/14728222.2012.714774 ↗
7. 10.1038/ncomms1059310.1038/ncomms10593 ↗
8. 10.3892/ijo.2014.262910.3892/ijo.2014.2629 ↗
9. 10.1006/exnr.1996.018410.1006/exnr.1996.0184 ↗
10. Grisendi G, Bussolari R, Veronesi E, et al. Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers. Am J Cancer Res. 2011;1:787–805.
11. 10.1158/0008-5472.CAN-08-045110.1158/0008-5472.CAN-08-0451 ↗
12. 10.1080/21691401.2016.124645210.1080/21691401.2016.1246452 ↗
13. 10.1155/2013/92898210.1155/2013/928982 ↗
14. 10.1038/cddis.2015.32710.1038/cddis.2015.327 ↗
15. 10.1038/nrd.2016.19310.1038/nrd.2016.193 ↗
16. 10.1586/era.09.2210.1586/era.09.22 ↗
17. 10.1634/stemcells.2007-059410.1634/stemcells.2007-0594 ↗
18. 10.1089/scd.2007.015410.1089/scd.2007.0154 ↗
19. 10.1089/scd.2007.015610.1089/scd.2007.0156 ↗
20. 10.1111/resp.1234310.1111/resp.12343 ↗
21. 10.1016/j.msard.2014.08.00210.1016/j.msard.2014.08.002 ↗
22. 10.1097/MIB.0b013e31827f27df10.1097/MIB.0b013e31827f27df ↗
23. 10.1002/stem.57210.1002/stem.572 ↗
24. 10.3892/ol.2012.77210.3892/ol.2012.772 ↗
25. 10.1371/journal.pone.003911910.1371/journal.pone.0039119 ↗
26. 10.1080/14653240410005267-110.1080/14653240410005267-1 ↗
27. 10.2147/IJN.S10114110.2147/IJN.S101141 ↗
28. 10.1080/21691401.2017.137901410.1080/21691401.2017.1379014 ↗
29. 10.1016/j.coph.2014.08.00210.1016/j.coph.2014.08.002 ↗
30. Wang YX. Superparamagnetic iron oxide based MRI contrast agents: current status of clinical application. Quant Imaging Med Surg. 2011;1:35–40.
31. 10.1002/nbm.92410.1002/nbm.924 ↗
32. Henning TD, Boddington S, Daldrup-Link HE. Labeling hESCs and hMSCs with iron oxide nanoparticles for non-invasive in vivo tracking with MR imaging. J Vis Exp. 2008;13:e685.
33. 10.2217/nnm.12.19810.2217/nnm.12.198 ↗
34. 10.1016/j.jpba.2010.07.00810.1016/j.jpba.2010.07.008 ↗
35. 10.5897/AJB11.104110.5897/AJB11.1041 ↗
36. 10.1016/j.nantod.2014.06.00510.1016/j.nantod.2014.06.005 ↗
37. 10.1021/la801985g10.1021/la801985g ↗
38. 10.1371/journal.pone.010805510.1371/journal.pone.0108055 ↗
39. 10.1152/ajpcell.00013.201010.1152/ajpcell.00013.2010 ↗
40. 10.1016/j.jneuroim.2012.02.00910.1016/j.jneuroim.2012.02.009 ↗
41. 10.18632/oncotarget.1651610.18632/oncotarget.16516 ↗
42. 10.1634/stemcells.2007-005410.1634/stemcells.2007-0054 ↗
43. 10.1002/jcb.2117210.1002/jcb.21172 ↗
44. 10.1128/JVI.05318-1110.1128/JVI.05318-11 ↗
45. 10.3109/08830185.2010.49893110.3109/08830185.2010.498931 ↗
46. 10.1016/j.cellbi.2006.03.00910.1016/j.cellbi.2006.03.009 ↗
47. 10.1002/pmic.20070119510.1002/pmic.200701195 ↗
48. 10.1002/stem.5010.1002/stem.50 ↗
49. 10.1182/blood-2006-10-05106010.1182/blood-2006-10-051060 ↗
50. 10.1158/0008-5472.CAN-04-187410.1158/0008-5472.CAN-04-1874 ↗
51. 10.1227/01.NEU.0000363149.58885.2E10.1227/01.NEU.0000363149.58885.2E ↗
52. 10.3171/2016.9.JNS1627810.3171/2016.9.JNS16278 ↗
53. 10.3389/fneur.2015.0015510.3389/fneur.2015.00155 ↗
54. 10.1186/scrt54410.1186/scrt544 ↗
55. 10.1007/s13277-013-1561-x10.1007/s13277-013-1561-x ↗
56. 10.1016/j.stem.2015.02.01510.1016/j.stem.2015.02.015 ↗
57. 10.2217/17460751.3.2.19910.2217/17460751.3.2.199 ↗
58. 10.3390/ma404070310.3390/ma4040703 ↗